Table 3 Thromboembolic events for the whole group
Whole Group (1677) | Patients with thrombosis (110) | ||||
|---|---|---|---|---|---|
Number | % | Number | % | p-value | |
Sex | |||||
Male | 1099 | 65.5 | 58 | 5.3 | 0.003 |
Female | 578 | 34.5 | 52 | 9.0 | |
Age (Years) | |||||
Missed | 1 | 0.6445 | |||
≤ 60 | 1276 | 76.1 | 81 | 6.3 | |
> 60 | 400 | 23.9 | 28 | 7.0 | |
Primary Tumor | |||||
Head and Neck | 384 | 22.9 | 9 | 2.3 | <0.0001 |
Lung | 373 | 22.2 | 25 | 6.7 | |
Gastric | 191 | 11.4 | 40 | 20.9 | |
Lymphoma | 191 | 11.4 | 3 | 1.6 | |
Testicular | 104 | 6.2 | 4 | 3.8 | |
Cervical | 121 | 7.2 | 7 | 5.8 | |
Bladder | 77 | 4.6 | 3 | 3.9 | |
Sarcoma | 45 | 2.7 | 3 | 6.7 | |
Esophageal | 33 | 2.0 | 6 | 18.2 | |
Others | 158 | 9.4 | 10 | 6.3 | |
Khorana Risk Score | |||||
Low risk | 350 | 20.9 | 16 | 4.6 | <0.0001 |
Intermediate risk | 1075 | 64.1 | 61 | 5.7 | |
High risk | 252 | 15.0 | 33 | 13.1 | |
Disease Stage | |||||
I | 56 | 3.3 | 3 | 5.4 | 0.0038 |
II | 213 | 12.7 | 8 | 3.8 | |
III | 487 | 29 | 20 | 4.1 | |
IV | 857 | 51.1 | 76 | 8.9 | |
Unstageable/Unknown | 64 | 3.8 | 3 | 4.7 | |